Literature DB >> 15830277

The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis.

Wataru Kitagawa1, Naoto Miura, Harutaka Yamada, Kazuhiro Nishikawa, Arao Futenma, Hirokazu Imai.   

Abstract

A 50-year-old woman was admitted because of high fever and fatigue. Proteinuria, hematuria, and elevated BUN (47.8 mg/dl) and creatinine (3.4 mg/dl) suggested rapidly progressive glomerulonephritis. The serological study revealed all negative results for rheumatoid factor, antinuclear antibody, serum cryoglobulins, MPO-ANCA, PR3-ANCA, and anti-streptolysin O. Antiglomerular basement membrane (GBM) antibody, as assessed by ELISA, was 11 EU (normal, <10). Kidney biopsy on the eighth hospital day demonstrated pauci-immune-type crescentic glomerulonephritis without ANCA. Methylprednisolone pulse therapy (500 mg/day, 3 days) and 45 mg/day prednisolone orally were started. At 3 weeks after kidney biopsy, the anti-GBM antibody value increased from 11 EU/ml to 116 EU/ml, and MPO and PR3-ANCA were still negative. HLA type was DR8 and DR 15(2), with a genotype of HLA-DRB1*08021 and HLA-DRB1*15011. The present case suggests that HLA-DR15 plays an important role on antibody production against alpha 3(IV) NC1 autoantigen after severe nephritis or tissue damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15830277     DOI: 10.1007/s10157-004-0334-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  1 in total

1.  Thrombotic thrombocytopenic purpura in a patient with rapidly progressive glomerulonephritis with both anti-glomerular basement membrane antibodies and myeloperoxidase anti-neutrophil cytoplasmic antibodies.

Authors:  Hitoshi Watanabe; Wataru Kitagawa; Keisuke Suzuki; Masabumi Yoshino; Ryuhei Aoyama; Naoto Miura; Kazuhiro Nishikawa; Hirokazu Imai
Journal:  Clin Exp Nephrol       Date:  2010-07-14       Impact factor: 2.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.